Transforming Estonian health data to the Observational Medical Outcomes Partnership (OMOP) Common Data Model: lessons learned

Author:

Oja MarekORCID,Tamm Sirli,Mooses KerliORCID,Pajusalu MaarjaORCID,Talvik Harry-AntonORCID,Ott Anne,Laht Marianna,Malk Maria,Lõo Marcus,Holm Johannes,Haug MarkusORCID,Šuvalov Hendrik,Särg DageORCID,Vilo JaakORCID,Laur SvenORCID,Kolde RaivoORCID,Reisberg SulevORCID

Abstract

ABSTRACTObjectiveTo describe the reusable transformation process of electronic health records (EHR), claims, and prescriptions data into Observational Medical Outcome Partnership (OMOP) common data model (CDM), together with challenges faced and solutions implemented.Materials and MethodsWe used Estonian national health databases that store almost all residents’ claims, prescriptions, and EHR records. To develop and demonstrate the transformation process of Estonian health data to OMOP CDM, we used a 10% random sample of the Estonian population (n = 150,824 patients) from 2012-2019. For the sample, complete information from all three databases was converted to OMOP CDM version 5.3. The validation was performed using open-source tools.ResultsIn total, we transformed over 100 million entries to standard concepts using standard OMOP vocabularies with the average mapping rate 95%. For conditions, observations, drugs, and measurements, the mapping rate was over 90%. In most cases, SNOMED Clinical Terms were used as the target vocabulary.DiscussionDuring the transformation process, we encountered several challenges, which are described in detail with concrete examples and solutions.ConclusionFor a representative 10% random sample, we successfully transferred complete records from three national health databases to OMOP CDM and created a reusable transformation process. Our work helps future researchers to transform linked databases into OMOP CDM more efficiently, ultimately leading to better real-world evidence.

Publisher

Cold Spring Harbor Laboratory

Reference41 articles.

1. Hubbard T , Paradis R. Real world evidence: a new era for health care innovation. NEHI - Network for Excellence in Health Innovation 2015. https://www.nehi-us.org/writable/publication_files/file/rwe_issue_brief_final.pdf

2. Real-World Evidence — What Is It and What Can It Tell Us?

3. Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices. Guidance for Industry and Food and Drug Administration Staff. 2017.https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-real-world-evidence-support-regulatory-decision-making-medical-devices

4. A review of uses of health care utilization databases for epidemiologic research on therapeutics

5. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3